Evidence map›Paper›PMID 38202810›Full record

ArticleMolecules (Basel, Switzerland)2023

Enhancing Flame Retardancy and Smoke Suppression in Epoxy Resin Composites with Sulfur-Phosphorous Reactive Flame Retardant.

Xulong Ma, Ni Kang, Yonghang Zhang, Yang Min, Jianhua Yang, Daming Ban, Wei Zhao

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 15 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xulong MaSchool of Chemistry and Materials Science, Guizhou Normal University, Guiyang 550001, China.
Ni KangSchool of Chemistry and Materials Science, Guizhou Normal University, Guiyang 550001, China.
Yonghang ZhangSchool of Chemistry and Materials Science, Guizhou Normal University, Guiyang 550001, China.
Yang MinSchool of Chemistry and Materials Science, Guizhou Normal University, Guiyang 550001, China.
Jianhua YangSchool of Chemistry and Materials Science, Guizhou Normal University, Guiyang 550001, China.
Daming BanSchool of Chemistry and Materials Science, Guizhou Normal University, Guiyang 550001, China.ORCID 0000-0002-3121-4429
Wei ZhaoTechnology and Engineering Center for Space Utilization, Chinese Academy of Sciences, Beijing 100094, China.ORCID 0000-0001-7298-238X
Guizhou Normal University · CNChinese Academy of Sciences · CN

Funding

Guiyang Science Project Zhu Ke Hetong[2021]43-4National Natural Science Foundation of China 51763005
6 · The paper itself

Abstract

The presence of massive amounts of toxic volatiles and smoke during combustion is a very serious problem facing epoxy resin (EP) composites. Therefore, flame retardants (FRs) can simultaneously enhance flame retardancy and reduce the release of smoke and fatal gases. Herein, a novel sulfur-phosphorous reactive flame retardant (SPMS) was synthesized for epoxy resin. The high efficiency of smoke suppression and flame retardancy of the EP/SPMS-APP hybrid was investigated using a cone calorimeter, a vertical burning test, and limited oxygen index measurements. Compared with those of pure EP, the composite with 20 wt% SPMS-APP reduced the peak heat release rate (pHRR), the peak smoke production rate (SPR), and total smoke production rate (TSR) by 82%, 94%, and 84%, respectively. The results showed a remarkable suppressed effect of alleviating the fire hazard of EP using a sulfur-phosphorus flame retardant.

Indexed as

flame retardantphosphaphenanthrenesmoke suppressionsuppressed effect

Identifiers

PMID38202810
PMCPMC10780495
OpenAlexW4390467942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.